XML 65 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Based Compensation (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares authorized 3,000,000      
Weighted Average Grant Date Fair Value of Restricted Stock        
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense     $ 95,000 $ 20,000
Shares Paid for Tax Withholding for Share Based Compensation     7,744 17,180
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 0      
Restricted Stock [Member]        
Restricted Stock Rollforward, Shares        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number     349,885  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     132,327  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     86,316  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period     11,036  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 384,860   384,860  
Weighted Average Grant Date Fair Value of Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value     $ 10.62  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     7.69  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value     13.97  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     15.37  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 9.90   $ 9.90  
Unrecognized compensation expense $ 2,377,000 $ 2,589,000   $ 2,589,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     2 years  
Restricted Stock [Member] | Selling, General and Administrative Expenses [Member]        
Weighted Average Grant Date Fair Value of Restricted Stock        
Compensation costs 350,000 259,000 $ 1,121,000 1,228,000
Stock Appreciation Rights (SARs) [Member]        
Weighted Average Grant Date Fair Value of Restricted Stock        
Unrecognized compensation expense $ 435,000 0   0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 7 months      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number     0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     226,021  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period     0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares     0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 226,021   226,021  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 29,028      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price     $ 0.00  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     2.57  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price     0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price     0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 2.57   $ 2.57  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value     $ 2.57  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term     4 years 7 months  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 10   $ 0.00  
Stock Appreciation Rights (SARs) [Member] | Selling, General and Administrative Expenses [Member]        
Weighted Average Grant Date Fair Value of Restricted Stock        
Compensation costs $ 42,000 0 $ 145,000 0
Foreign Exchange Forward [Member] | Cost of Sales [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 55,000 (11,000) 110,000 184,000
Foreign Exchange Forward [Member] | Selling, General and Administrative Expenses [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 8,000 (9,000) 0 21,000
Interest Rate Swap [Member] | Interest Expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ (14,000) $ (61,000) $ (13,000) $ (169,000)